Ständer, S., & Thaçi, D. Interleukin-23p19 inhibitors for the treatment of moderate-to-severe psoriasis: An expert opinion of real-world evidence studies in Europe. Taylor & Francis Group.
Chicago Style (17th ed.) CitationStänder, S., and D. Thaçi. Interleukin-23p19 Inhibitors for the Treatment of Moderate-to-severe Psoriasis: An Expert Opinion of Real-world Evidence Studies in Europe. Taylor & Francis Group.
MLA (9th ed.) CitationStänder, S., and D. Thaçi. Interleukin-23p19 Inhibitors for the Treatment of Moderate-to-severe Psoriasis: An Expert Opinion of Real-world Evidence Studies in Europe. Taylor & Francis Group.
Warning: These citations may not always be 100% accurate.